François Eyskens

1.7k citations

39 papers · 796 · h-index 17

Impact in

Clinical Biochemistry top 1%
- Metabolism and Genetic Disorders
Biochemistry top 10%
- Amino Acid Enzymes and Metabolism

Papers in

Clinical Biochemistry 17
- Metabolism and Genetic Disorders 17
Molecular Biology 15
- Peroxisome Proliferator-Activated Receptors 4

Co-authors: Rudy Van Coster (3 shared papers)Joél Smet (3 shared papers)Sara Seneca (2 shared papers)Linda De Meırleır (1 shared paper)Inge De Clercq (1 shared paper)Willy Lissens (1 shared paper)E. Gerlo (1 shared paper)Dirk Van West (3 shared papers)
Journals: Orphanet Journal of Rare Diseases (3 papers)Pediatric Research (2 papers)Molecular Genetics and Metabolism (2 papers)Clinical Neurology and Neurosurgery (1 paper)PLoS ONE (1 paper)
Partner nations: Belgium United Kingdom United States

In The Last Decade

François Eyskens

35 papers receiving 782 citations

Peers

Countries citing papers authored by François Eyskens

Since Specialization

Citations

This map shows the geographic impact of François Eyskens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Eyskens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Eyskens more than expected).

Fields of papers citing papers by François Eyskens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Eyskens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Eyskens. The network helps show where François Eyskens may publish in the future.

Co-authors

The 25 scholars most cited alongside François Eyskens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with François Eyskens Line = papers co-authored together François Eyskens links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Respiratory chain complex V deficiency due to a mutation in the assembly gene ATP12 Journal of Medical Genetics ·Linda De Meırleır, Sara Seneca, Willy Lissens, Inge De Clercq, François Eyskens, E. Gerlo, Joél Smet, Rudy Van Coster	2004	146
2	Mutation of the iron-sulfur cluster assembly gene IBA57 causes severe myopathy and encephalopathy Human Molecular Genetics ·Nikhita Bolar, Arnaud Vanlander, Claudia Wilbrecht, Nathalie Van der Aa, Joél Smet, Boél De Paepe, Geert Vandeweyer, R. Frank Kooy, François Eyskens, Elien De Latter, Gwenda Delanghe, Paul Govaert, Jules G. Leroy, Bart Loeys, Roland Lill, Lut Van Laer, Rudy Van Coster	2013	92
3	Deletion of PREPL, a Gene Encoding a Putative Serine Oligopeptidase, in Patients with Hypotonia-Cystinuria Syndrome The American Journal of Human Genetics ·Jaak Jaeken, Kevin Martens, Inge François, François Eyskens, C Lecointre, Rita Derua, Sandra Meulemans, Jerry W. Slootstra, Etienne Waelkens, Francis de Zegher, John W.M. Creemers, Gert Matthijs	2005	62
4	Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls Orphanet Journal of Rare Diseases ·Willem G. van Ginkel, Rianne Jahja, Stephan C. J. Huijbregts, Anne Daly, Anita MacDonald, Corinne De Laet, David Cassiman, François Eyskens, Irene M. L. W. Körver‐Keularts, Philippe Goyens, Patrick McKiernan, Francjan J. van Spronsen	2016	55
5	Identifying Non–Duchenne Muscular Dystrophy–Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs JAMA Neurology ·Michele A. Gatheridge, Jennifer M. Kwon, J. Mendell, Günter Scheuerbrandt, Stuart J. Moat, François Eyskens, Cheryl R. Greenberg, Anthi Drousiotou, Robert C. Griggs	2015	52
6	Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase PLoS ONE ·David G. Warnock, Daniel G. Bichet, Myrl Holida, Özlem Göker-Alpan, Kathy Nicholls, Mark Thomas, François Eyskens, Suma P. Shankar, Mathews Adera, Sheela Sitaraman, Richie Khanna, John J. Flanagan, Brandon A. Wustman, Jay Barth, Carrolee Barlow, Kenneth J. Valenzano, David J. Lockhart, Pol Boudes, Franklin K. Johnson	2015	49
7	A nonsense mutation in the 3-hydroxy-3-methylglutaryl-CoA lyase gene produces exon skipping in two patients of different origin with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency Biochemical Journal ·Juan Pié, Núria Casals, César H. Casale, Carlos Buesa, Cristina Mascaró, Anna Barceló, Marie-Odile Rolland, Theresa ZABOT, Diego Haro, François Eyskens, P. Divry, Fausto G. Hegardt	1997	33
8	Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients <4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial Orphanet Journal of Rare Diseases ·Ania C. Muntau, Alberto Burlina, François Eyskens, Peter Freisinger, Corinne De Laet, Vincenzo Leuzzi, Frank Rutsch, Serap Sivri, Suresh Vijay, Milva Orquidea Bal, Gwendolyn Gramer, Renata Pazdírková, Maureen Cleary, Amelie S. Lotz‐Havla, Alain Munafo, Diane R. Mould, Flavie Moreau-Stucker, Daniela Rogoff	2017	30
9	Hyperoxaluria with hyperglycoluria not due to alanine:glyoxylate aminotransferase defect: A novel type of primary hyperoxaluria Kidney International ·K. J. Van Acker, François Eyskens, Marc Espeel, R. J. A. Wanders, Conny Dekker, Ingrid Kerckaert, Frank Roels	1996	26
10	Can psychiatric childhood disorders be due to inborn errors of metabolism? European Child & Adolescent Psychiatry ·Annik Simons, François Eyskens, Inge Glazemakers, Dirk Van West	2016	24
11	Cytomegalovirus DNA Detection in Guthrie Cards Otology & Neurotology ·An Boudewyns, Frank Declau, Koenraad Smets, D. Ursi, François Eyskens, Jenneke van den Ende, Paul Van de Heyning	2009	21
12	Long-term follow-up on the effect of combined therapy of bile acids and statins in the treatment of cerebrotendinous xanthomatosis: A case report Clinical Neurology and Neurosurgery ·Evelien Luyckx, François Eyskens, Annik Simons, Katrien Beckx, Dirk Van West, Monica Dhar	2014	21
13	Data mining methods for classification of Medium-Chain Acyl-CoA dehydrogenase deficiency (MCADD) using non-derivatized tandem MS neonatal screening data Journal of Biomedical Informatics ·Tim Van den Bulcke, Paul Vanden Broucke, Viviane Van Hoof, Kristien Wouters, Seppe vanden Broucke, Geert A.H.J. Smits, Elke Smits, Sam Proesmans, Toon Van Genechten, François Eyskens	2010	19
14	Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial Orphanet Journal of Rare Diseases ·Ania C. Muntau, A Burlina, François Eyskens, Peter Freisinger, Vincenzo Leuzzi, Sivri Hs, Gwendolyn Gramer, Renata Pazdírková, Maureen Cleary, Amelia S. Lotz-Havla, Paul Lane, Ignacio Alvarez, Frank Rutsch	2021	17
15	Bone Health in Classic Galactosemia: Systematic Review and Meta-Analysis JIMD Reports ·Britt van Erven, Lindsey Welling, Sandra C. Van Calcar, Artemis Doulgeraki, François Eyskens, Joanna Gribben, Eileen P. Treacy, Rein Vos, Susan E. Waisbren, M. Estela Rubio‐Gozalbo, Annet M. Bosch	2016	17
16	Novel Mutations in the PEX2 Gene of Four Unrelated Patients with a Peroxisome Biogenesis Disorder Pediatric Research ·Jeannette Gootjes, Orly Elpeleg, François Eyskens, Hanna Mandel, Delphine Mitanchez, Nobuyuki Shimozawa, Yasuyuki Suzuki, Hans R. Waterham, Ronald J. A. Wanders	2003	17
17	Genotype-phenotype correlation in PEX5-deficient peroxisome biogenesis defective cell lines Human Mutation ·Merel S. Ebberink, P. A. W. Mooyer, Janet Koster, Conny Dekker, François Eyskens, Carlo Dionisi‐Vici, Peter T. Clayton, P. G. Barth, Ronald J. A. Wanders, Hans R. Waterham	2008	16
18	Mitochondrial mosaics in the liver of 3 infants with mtDNA defects BMC Clinical Pathology ·Frank Roels, Patrick Verloo, François Eyskens, Baudouin François, Sara Seneca, Boél De Paepe, Jean‐Jacques Martin, Valérie Meersschaut, Marleen Praet, Emmanuel Scalais, Marc Espeel, Joél Smet, Gert Van Goethem, Rudy Van Coster	2009	12
19	Galactosidase Alpha p.A143T Variant Fabry Disease May Result in a Phenotype With Multifocal Microvascular Cerebral Involvement at a Young Age Frontiers in Neurology ·Lothar Hauth, Jeroen Kerstens, Laetitia Yperzeele, François Eyskens, Paul M. Parizel, Barbara Willekens	2018	12
20	Urinary Excretion of Purine and Pyrimidine Metabolites in the Neonate Pediatric Research ·K. J. Van Acker, François Eyskens, Robert Verkerk, Simon Scharpé	1993	9

About François Eyskens

François Eyskens is a scholar working on Clinical Biochemistry, Molecular Biology, Physiology, Pediatrics, Perinatology and Child Health and Epidemiology, having authored 39 papers that have together received 796 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (17 papers), Lysosomal Storage Disorders Research (10 papers), Neonatal Health and Biochemistry (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Folate and B Vitamins Research (3 papers), Carbohydrate Chemistry and Synthesis (3 papers), Diet and metabolism studies (3 papers) and Trypanosoma species research and implications (2 papers). The work is most often cited by research in Clinical Biochemistry (311 citations), Biochemistry (69 citations), Molecular Biology (425 citations), Physiology (136 citations) and Rheumatology (70 citations). François Eyskens has collaborated with scholars based in Belgium, United Kingdom and United States. Frequent co-authors include Rudy Van Coster, Joél Smet, Sara Seneca, Linda De Meırleır, Inge De Clercq, Willy Lissens, E. Gerlo, Dirk Van West, Robert C. Griggs and Boél De Paepe. Their work appears in journals such as Orphanet Journal of Rare Diseases, Pediatric Research, Molecular Genetics and Metabolism, Clinical Neurology and Neurosurgery and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

François Eyskens

Impact in

Papers in i

In The Last Decade

François Eyskens

Peers

Countries citing papers authored by François Eyskens

Fields of papers citing papers by François Eyskens

All Works

About François Eyskens

Explore authors with similar magnitude of impact

Papers in